8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
Pooled results from many studies on one question.
2016 / Systematic review of prospective observational studies
A systematic review examined 13 observational studies investigating potato consumption and risks of adiposity, type 2 diabetes, and cardiovascular disease in healthy adults. Total potato intake showed neutral or mixed links with adiposity and diabetes, with no observed association for cardiovascular disease. However, french fries were positively associated with increased adiposity across 3 studies and with type 2 diabetes across 3 studies.
Shows an association, not proof of cause and effect.
Borch D, Juul-Hindsgaul N, Veller M, et al. Am J Clin Nutr, 2016. PMID 27413134
2016 / Meta-analysis of randomized controlled trials
A meta-analysis of 10 articles (12 randomized controlled trials) evaluated the effects of fenugreek on glycemic and lipid parameters in diabetes and prediabetes. Pooled results showed fenugreek significantly reduced fasting blood glucose (MD -0.84 mmol/L; 95% CI -1.38 to -0.31; p=0.002), 2-hour postprandial glucose (MD -1.30 mmol/L; 95% CI -1.78 to -0.83; p<0.0001), HbA1c (MD -1.16; 95% CI -1.23 to -1.09; p<0.00001), and total cholesterol (MD -0.30 mmol/L; 95% CI -0.56 to -0.03; p=0.03). Changes in triglycerides, LDL-c, and HDL-c were not statistically significant or required further verification. No liver or kidney toxicity was reported, with gastrointestinal discomfort being the main side effect, though some included studies were of low quality.
Gong J, Fang K, Dong H, et al. J Ethnopharmacol, 2016. PMID 27496582
2016 / Systematic review of interventional and observational studies
A systematic review evaluated 19 human studies (13 interventional and 6 observational) examining sorghum consumption and diverse health metrics. Sorghum intake attenuated blood glucose responses and lowered expressions of oxidative stress markers. Additionally, sorghum appeared viable for oral rehydration formulas and exhibited potential to enhance immune responses in HIV-positive individuals.
Shows an association, not proof of cause and effect.
Simnadis TG, Tapsell LC, Beck EJ Nutr Rev, 2016. PMID 27694643
2016 / Dose-response meta-analysis of prospective studies
A systematic review and dose-response meta-analysis evaluated 20 prospective studies examining nut consumption and mortality outcomes in adults. A 28 g/day increase in nut intake was associated with reduced risk of coronary heart disease (RR 0.71, 95% CI: 0.63-0.80), cardiovascular disease (RR 0.79, 95% CI: 0.70-0.88), total cancer (RR 0.85, 95% CI: 0.76-0.94), and all-cause mortality (RR 0.78, 95% CI: 0.72-0.84). Inverse associations were also observed for mortality from respiratory disease (RR 0.48), diabetes (RR 0.61), and infectious disease (RR 0.25), with similar findings for tree nuts and peanuts.
Shows an association, not proof of cause and effect.
Aune D, Keum N, Giovannucci E, et al. BMC Med, 2016. PMID 27916000
2015 / Systematic review and meta-analysis of randomized controlled trials
A meta-analysis analyzed 27 randomized controlled clinical trials involving 2,569 patients. For type 2 diabetes, berberine with lifestyle intervention or oral hypoglycemics tended to lower FPG, PPG, and HbA1c more than lifestyle intervention alone, placebo, or hypoglycemics alone, though berberine alone did not significantly differ from oral hypoglycemics. For hyperlipidemia, berberine combined with lifestyle intervention or lipid-lowering drugs was better at reducing TC and LDL-C and raising HDL-C. For hypertension, berberine with lifestyle intervention or hypotensors lowered blood pressure more than controls. No serious adverse reactions were reported, but the authors concluded that due to limited overall study quality, the therapeutic benefit could be substantiated to a limited degree.
Lan J, Zhao Y, Dong F, et al. J Ethnopharmacol, 2015. PMID 25498346
2015 / Meta-analysis of prospective cohort studies
A meta-analysis evaluated 15 prospective cohorts encompassing 1,020,642 participants. Top-tier adherence to HEI, AHEI, or DASH was associated with lower total mortality (RR 0.78, 95% CI 0.76 to 0.80), cardiovascular events or death (RR 0.78, 95% CI 0.75 to 0.81), malignancies (RR 0.85, 95% CI 0.82 to 0.88), and type 2 diabetes (RR 0.78, 95% CI 0.72 to 0.85). Neurodegenerative conditions showed no significant relationship.
Shows an association, not proof of cause and effect.
Schwingshackl L, Hoffmann G J Acad Nutr Diet, 2015. PMID 25680825
2015 / Systematic review and meta-analysis of observational studies
A meta-analysis evaluated eight observational studies examining the association between breakfast skipping and type 2 diabetes (T2D) risk. In cohort studies, the pooled adjusted relative risk of T2D associated with breakfast skipping was 1.21 (95% CI 1.12, 1.31; P=0.984; I²=0.0%). In cross-sectional studies, the pooled odds ratio was 1.15 (95% CI 1.05, 1.24; P=0.770; I²=0.0%), with funnel plot inspection and Begg's test indicating no evidence of publication bias.
Shows an association, not proof of cause and effect.
Bi H, Gan Y, Yang C, et al. Public Health Nutr, 2015. PMID 25686619
2015 / Meta-analysis
A systematic review and meta-analysis analyzed 38 studies evaluating the link between arsenic exposure and diabetes mellitus. Among 32 studies examining the ingestion route, arsenic intake was associated with a higher risk of diabetes (RR = 1.57; 95% CI: 1.27-1.93). Restricting the analysis to 24 studies with laboratory- or record-confirmed diagnoses yielded a similar summary relative risk of 1.71 (95% CI: 1.32-2.23).
Sung TC, Huang JW, Guo HR Biomed Res Int, 2015. PMID 26000288
2015 / Metaepidemiological study / network meta-analysis
Researchers performed a network meta-analysis of 16 meta-analyses plus three recent trials (305 RCTs total, 339,274 participants) comparing exercise and drug interventions on mortality across four conditions. No statistically detectable differences appeared between exercise and drug interventions in coronary heart disease secondary prevention or prediabetes. Exercise was more effective than anticoagulants (OR 0.09, 95% CrI 0.01 to 0.70) and antiplatelets (OR 0.10, 0.01 to 0.62) for stroke rehabilitation, whereas diuretics outperformed exercise in heart failure (exercise v diuretics OR 4.11, 1.17 to 24.76). Authors noted existing randomized trial evidence on exercise interventions remains limited in quantity.
Naci H, Ioannidis JP Br J Sports Med, 2015. PMID 26476429
2015 / Systematic review and meta-analysis of controlled intervention trials
A systematic review and meta-analysis of 61 controlled intervention trials (n = 2582, durations 3 to 26 weeks) evaluated the effects of tree nuts on cardiovascular risk markers. Per 1-oz (28.4 g) serving per day, nut intake lowered total cholesterol (-4.7 mg/dL; 95% CI: -5.3, -4.0 mg/dL), LDL cholesterol (-4.8 mg/dL; 95% CI: -5.5, -4.2 mg/dL), ApoB (-3.7 mg/dL; 95% CI: -5.2, -2.3 mg/dL), and triglycerides (-2.2 mg/dL; 95% CI: -3.8, -0.5 mg/dL), with no significant effects on other outcomes. The dose-response for total and LDL cholesterol was nonlinear (P-nonlinearity < 0.001 each), showing stronger effects at ≥60 g/d. ApoB reductions were stronger in populations with type 2 diabetes (-11.5 mg/dL) than in healthy participants (-2.5 mg/dL; P-heterogeneity = 0.015).
Del Gobbo LC, Falk MC, Feldman R, et al. Am J Clin Nutr, 2015. PMID 26561616
2015 / Systematic review and meta-analysis of randomized controlled trials
A meta-analysis of 13 randomized controlled trials assessed replacing animal protein with plant protein in 280 individuals with diabetes. Substituting plant sources for approximately 35% of daily protein significantly decreased HbA1c (MD = -0.15%; 95% CI: -0.26, -0.05%), fasting glucose (MD = -0.53 mmol/L; 95% CI: -0.92, -0.13 mmol/L), and fasting insulin (MD = -10.09 pmol/L; 95% CI: -17.31, -2.86 pmol/L).
Viguiliouk E, Stewart SE, Jayalath VH, et al. Nutrients, 2015. PMID 26633472
2015 / Systematic review and meta-analysis
A systematic review and meta-analysis of 14 controlled trials and two uncontrolled observational studies assessed the effects of oat intake in diabetic patients. Compared with controls, oat intake significantly reduced HbA1c (MD, -0.42%; 95% CI, -0.61% to -0.23%), fasting blood glucose (MD, -0.39 mmol/L; 95% CI, -0.58 to -0.19 mmol/L), total cholesterol (MD, -0.49 mmol/L; 95% CI, -0.86 to -0.12 mmol/L), and LDL-C (MD, -0.29 mmol/L; 95% CI, -0.48 to -0.09 mmol/L). Oatmeal also significantly reduced acute postprandial glucose and insulin responses compared with control meals. The authors noted that further studies on type 1 diabetes and safety are needed.
Hou Q, Li Y, Li L, et al. Nutrients, 2015. PMID 26690472
2014 / Systematic review and meta-analysis of randomized controlled trials
A systematic review of 26 randomized controlled trials with 831 participants evaluated dietary prebiotic supplementation. Prebiotics increased self-reported satiety in healthy adults (SMD -0.57, 95% CI -1.13 to -0.01) and decreased postprandial glucose (SMD -0.76, 95% CI -1.41 to -0.12) and insulin concentrations (SMD -0.77, 95% CI -1.50 to -0.04). Findings regarding body weight, total energy intake, lipids, inflammatory markers, and gut hormones remained contradictory.
Kellow NJ, Coughlan MT, Reid CM Br J Nutr, 2014. PMID 24230488
2014 / Pooled analysis of four 21-day intervention studies
A pooled analysis evaluated data from four 21-day intervention studies investigating the Ma-Pi 2 macrobiotic diet in adults with type 2 diabetes across Cuba, China, Ghana, and Italy. All measured biochemical, body composition, and blood pressure indicators showed significant changes (p < 0.001), most displaying high or very high effect sizes. The global effect sizes were 1.96 in Italy, 1.79 in China, 1.38 in Cuba, and 0.98 in Ghana. The diet significantly reduced glycemia, serum lipids, uremia, and cardiovascular risk, pointing to the need for further clinical studies.
Porrata-Maury C, Hernández-Triana M, Ruiz-Álvarez V, et al. Diabetes Metab Res Rev, 2014. PMID 24532293
2014 / Meta-analysis of prospective cohorts
A meta-analysis of seven published studies plus ELSA evaluated incident type 2 diabetes among 1,770 healthy obese adults with 98 cases. Compared with healthy normal-weight individuals, the pooled relative risk for developing type 2 diabetes was 4.03 (95% CI: 2.66-6.09) in healthy obese adults and 8.93 (95% CI: 6.86-11.62) in unhealthy obese adults. Significant heterogeneity was noted across the cohorts (I2 = 49.8%, P = 0.03).
Shows an association, not proof of cause and effect.
Bell JA, Kivimaki M, Hamer M Obes Rev, 2014. PMID 24661566
2014 / Meta-analysis of prospective cohorts
A meta-analysis analyzed 31 reports from 18 prospective studies to assess nut consumption and disease risk. Per daily serving, multivariable-adjusted pooled relative risks were 0.72 (95% CI: 0.64, 0.81) for ischemic heart disease, 0.71 (95% CI: 0.59, 0.85) for cardiovascular disease, and 0.83 (95% CI: 0.76, 0.91) for all-cause mortality. Associations with type 2 diabetes were attenuated after adjusting for body mass index, and stroke was not significantly associated.
Shows an association, not proof of cause and effect.
Luo C, Zhang Y, Ding Y, et al. Am J Clin Nutr, 2014. PMID 24847854
2014 / Meta-analysis of prospective studies
This meta-analysis synthesized data from prospective cohorts and clinical trials examining Mediterranean diet patterns and incident diabetes. Across 136,846 individuals, highest versus lowest adherence categories were associated with a 23% lower risk of developing type 2 diabetes (combined RR 0.77, 95% CI 0.66 to 0.89). Findings remained consistent across subgroup analyses, though original studies varied in adherence scoring methods and duration of follow-up.
Shows an association, not proof of cause and effect.
NANO counterpoint →
Koloverou E, Esposito K, Giugliano D, et al. Metabolism, 2014. PMID 24931280
2014 / Systematic review and meta-analysis of randomized controlled trials
In a meta-analysis of 35 randomized trials with 43,407 participants, vitamin D3 supplementation did not significantly affect insulin resistance (MD -0.04; 95% CI -0.30 to 0.22), beta-cell function (MD 1.64; 95% CI -25.94 to 29.22), or hemoglobin A1c (MD -0.05%; 95% CI -0.12 to 0.03). In four trials assessing progression to diabetes, risk did not differ from control (OR 1.02; 95% CI 0.94 to 1.10). Adverse events were rare.
Seida JC, Mitri J, Colmers IN, et al. J Clin Endocrinol Metab, 2014. PMID 25062463
2014 / Meta-analysis of prospective cohort studies
A meta-analysis of 10 articles including 13 comparisons across 434,342 participants with 24,013 type 2 diabetes cases evaluated fruit and vegetable consumption. An extra daily serving of fruit was linked to reduced risk (RR 0.93; 95% CI 0.88 to 0.99), as was each 0.2 daily serving of green leafy vegetables (RR 0.87; 95% CI 0.81 to 0.93). Combined fruit and vegetable intake showed no significant association.
Shows an association, not proof of cause and effect.
Li M, Fan Y, Zhang X, et al. BMJ Open, 2014. PMID 25377009
2014 / Systematic review and meta-analysis of controlled clinical trials
A systematic review and meta-analysis evaluated six controlled trials with 255 adults (mean age 42.5 years) to assess the effects of vegetarian diets on glycemic control in type 2 diabetes. Consumption of vegetarian diets was associated with a significant reduction in HbA1c (-0.39 percentage point; 95% CI, -0.62 to -0.15; P=0.001) compared with control diets. Fasting blood glucose showed a non-significant reduction (-0.36 mmol/L; 95% CI, -1.04 to 0.32; P=0.301).
Yokoyama Y, Barnard ND, Levin SM, et al. Cardiovasc Diagn Ther, 2014. PMID 25414824
2014 / Meta-analysis of randomized controlled clinical trials
A meta-analysis evaluated randomized controlled trials investigating the effects of garlic powder intake on cardiovascular disease risk factors. Garlic powder intake significantly reduced total cholesterol by -0.41 mmol/L (-15.83 mg/dL) and LDL-C by -0.21 mmol/L (-8.11 mg/dL). It also lowered fasting blood glucose by -0.96 mmol/L (-17.30 mg/dL), systolic blood pressure by -4.34 mmHg, and diastolic blood pressure by -2.36 mmHg.
Kwak JS, Kim JY, Paek JE, et al. Nutr Res Pract, 2014. PMID 25489404
2013 / Prospective cohort and meta-analysis
In 1,095 women from the Nurses' Health Study with 48 incident type 2 diabetes cases, plasma hexachlorobenzene (HCB) was positively associated with diabetes (pooled OR 3.59; 95% CI: 1.49, 8.64). Combining these findings with six prospective studies totaling 842 cases, diabetes was associated with both HCB (pooled OR 2.00; 95% CI: 1.13, 3.53) and total polychlorinated biphenyls (pooled OR 1.70; 95% CI: 1.28, 2.27).
Shows an association, not proof of cause and effect.
Wu H, Bertrand KA, Choi AL, et al. Environ Health Perspect, 2013. PMID 23131992
2013 / Meta-analysis and narrative overview
Researchers conducted an overview and a meta-analysis of studies up to October 2012 examining meat consumption and risks of diabetes and complications. For type 2 diabetes, the pooled relative risk per 100 g was 1.15 (95% CI 1.07-1.24) for total meat, 1.13 (95% CI 1.03-1.23) for unprocessed red meat, and 1.04 (95% CI 0.99-1.33) for poultry. Per 50 g of processed meat, the pooled relative risk was 1.32 (95% CI 1.19-1.48). The review noted that evidence is strongest for type 2 diabetes, coronary heart disease, and stroke, with processed meat showing the strongest association with type 2 diabetes.
Shows an association, not proof of cause and effect.
Feskens EJ, Sluik D, van Woudenbergh GJ Curr Diab Rep, 2013. PMID 23354681
2013 / Systematic review
This technical report reviewed literature informing pediatric type 2 diabetes management guidelines. The primary search identified 58 eligible studies on treatment, which were categorized into medical treatments, nonmedical interventions, provider behaviors, and social issues. A secondary search included 26 studies regarding diabetes comorbidities, noting a general scarcity of pediatric evidence and conflicting literature regarding screening and treatments.
Springer SC, Silverstein J, Copeland K, et al. Pediatrics, 2013. PMID 23359584